Amgen enjoyed its biggest one-day stock gain since 2009 after top executives delivered positive comments about its obesity candidate MariTide.

A team of researchers sought to determine the efficacy of psilocybin as an antidepressant compared with placebo or ...

Leading oncology drug developers raise $67 million in funding to target cancer's vulnerability to oncogene overactivation.

Moonwalk will show their first data for their two major platform components: the EpiRead and EpiWrite technologies.

The more quickly manufacturing and release obstructions can be cleared, the sooner lifesaving treatments can be administered.

Researchers at the Karolinska Institute may have found a new way to treat obesity and related disorders by targeting the ...

A schematic diagram of the influenza virus, showing the surface proteins hemagglutinin (blue, peanut shaped) and ...

What we know so far about the H5N1 influenza strain, otherwise known as “bird flu” or “avian flu,” and its spread in the ...

The Producer service offers customers a second option for accessing Asimov's technology for the cell and gene therapy ...

A new study shows that an inhibitor called ESI1 could potentially treat multiple sclerosis and other conditions associated with demyelination.

Collaboration is designed to accelerate the clinical progression of the next generation of cell and exosome therapeutics.

When asked about the most challenging part of turning TILs into therapies, it is expanding a sample into billions of cells.